Impact of Rituximab Maintenance on outcomes in Follicular Lymphoma: An indian experience
{{output}}
Background: Follicular lymphoma (FL) is the second most common subtype of non-Hodgkin lymphoma (NHL) and comprises 9 % of total NHL in India. Rituximab maintenance (RM) after induction immunochemotherapy improves PFS. However, cu... ...
